2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Authors/Task Force members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies

doi:https://doi.org/10.1016/j.atherosclerosis.2019.08.014

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

DSpace/Manakin Repository

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Authors/Task Force members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies

(2019) Atherosclerosis, volume 290, pp. 140 - 205

(Article)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Apolipoprotein B, Cholesterol;, Dyslipidaemias, Familial hypercholesterolaemia, Guidelines, High-density lipoproteins, Lipoprotein remnants, Lipoprotein(a), Low-density lipoproteins, Total cardiovascular risk, Treatment (adherence), Treatment (drugs), Treatment (lifestyle), Triglycerides, Very low-density lipoproteins, Cardiology and Cardiovascular Medicine, Journal Article

DOI: https://doi.org/10.1016/j.atherosclerosis.2019.08.014

ISSN: 0021-9150

Publisher: Elsevier

(Peer reviewed)